Generic abortion pill maker sues FDA to preserve access and protect drug.

GenBioPro, the manufacturer of a generic form of the abortion pill mifepristone, is suing the FDA to preserve access to the drug as anti-abortion rights groups challenge the FDA's approval of the drug. A temporary stay from the Supreme Court preserving access to mifepristone expires today, and if it expires, an order from the 5th U.S. Circuit Court of Appeals would take effect and impose multiple restrictions, including prohibiting the pills from being distributed by mail. GenBioPro's generic form of the drug accounts for about two-thirds of mifepristone sold in the United States.